Therapeutics
Treatment is aimed at relieving immediate respiratory distress, managing acute and persistent coughing, and addressing underlying co-existing or exacerbating factors (e.g., concurrent congestive heart failure or laryngeal paralysis).
These have been reviewed in more detail elsewhere (Sun et al. 2008 ; Herrtage 2009; Maggiore 2013; Hawkins and Papich 2014; Scansen and Weisse 2014).Supportive Measures
• Avoiding collars
• Weight loss
• Environmental temperature control and humidification
• Avoiding airway irritants
• Minimizing anxiety
• Controlled exercise - provided it is does not cause coughing or respiratory distress
• Management of concurrent diseases.
Medical Treatments
• Oxygen therapy
• Anxiolytics (opioids, acepromazine, trazodone, or others)
• Antitussives
î Opioids (butorphanol, hydrocodone, and others)
î Nebulized lignocaine and furosemide (reported in human medicine but very little literature in veterinary medicine)
• Corticosteroids (Parental, oral, and inhaled)
• Bronchodilators - no proven benefits, but have traditionally been used and are recommended in texts. A therapeutic trial can be attempted.
• Antibiotics. Tracheal collapse is a non- infectious disorder thus no need for antibiotics unless bacterial infections complicate the case.
• Experimental treatment
î Stanozolol (Adamama-Moraitou et al. 2011)
• Unproved/ineffective/low evidence based therapies (although often used in practice) î Doxycycline (unless susceptible infectious airway disease is present)
î Polysulfated glycosaminoglycan
î Neurokinin-1 receptor antagonist - maropitant (Grobman et al. 2015a; Grobman et al. 2015b)
Surgical Options (Sun et al. 2008; Chisnell and Pardo 2015)
• External tracheal ring prostheses
• Intraluminal stent.
• Procedures largely replaced by the above î Dorsal tracheal ligament plication
î Tracheal ring chondrotomy î Prosthetic polypropylene mesh reconstruction
The Asymptomatic Patient
When tracheal collapse is identified incidentally, or as asymptomatic disease (those with only the occasional spontaneous cough and without respiratory compromise) treatment is usually not required.
Emphasis is placed on addressing concurrent co-associated disorders (e.g., chronic bronchitis) and supportive measures. Confirming the diagnosis in this group of patients by tracheoscopy is unlikely to change the treatment.The Coughing Patient Without
Respiratory Compromise
Medical management as an outpatient is usually sufficient. The diagnostic and therapeutic approach is aimed at diagnosing collapsing trachea; identifying associated disorders; and addressing and applying supportive measures, including antitussives. Glucocorticoids, preferably inhaled formulations, remain central to controlling secondary airway inflammation and coughing, especially with the evidence that bronchomalacia is associated with chronic inflammatory airway disease. Corticosteroids are titrated to
the lowest effective dose. Initial clinical improvement with medical therapy can be expected in over two-thirds of patients (White and Williams 1994).
The (Coughing or Noncoughing) Patient with Respiratory Compromise
Generally, these patients have been previously diagnosed and are already on treatment. Medical and supportive management has been applied, but is no longer effective. Respiratory distress may be episodic, resolving spontaneously, or severe and persistent with the patient presenting as a respiratory emergency, severely compromised. Immediate treatment goals are aimed at decreasing the breathing rate and effort by supportive measures, such as cooling, and medical treatment. These include oxygen therapy, decreasing anxiety (i.e., decreasing hyperventilation), antitus- sive therapy (coughing exacerbates airway collapse), short-acting glucocorticoids, bronchodilators when bronchoconstriction is a comorbid problem, and providing ventilator support when in extremis by means of intubation with positive pressure ventilation (PPV). It is important to note that supplying oxygen by facemask or oxygen chambers may have limited success in patients with severe tracheal collapse as these animals are unable to ventilate and move oxygen enriched air into the lungs.
Patients that require PPV will mostly require a surgical solution. If PPV is not available, then endotracheal intubation will be necessary. Placing an oxygen delivering feeding tube through an endotracheal tube to the level of the carina will bypass tracheal (but not bronchial) collapse. Unless a stent is readily available for placement or the precipitating factor that induced ventilation failure can be rapidly corrected (e.g., severe panting due to heat stroke), intubation and ventilation will not aid long-term survival and euthanasia should be considered. While PPV is not ideal; it may provide a sufficient bridge in those dogs that have an acute reversible exacerbating factor.
In patients with episodic airway compromise, managing the whole airway is crucial. Diagnosing and correcting problems that increase airway resistance (such a chronic rhinitis, narrow nares, elongated soft palate, laryngeal collapse, everted laryngeal ventricles, and chronic lower airway inflammatory disease) will alleviate airway collapse by decreasing the effort required to breathe, without directly affecting the underlying tracheal collapse, and hopefully delaying the need for surgical intervention.
When respiratory compromise progresses or becomes refractory, surgical options remain the only means of providing relief in cases of airway collapse (Sun et al. 2008). Failure to administer medication is not a valid reason to seek surgical solutions, as most animals will require additional medical management afterwards.